Table 2.
Demographic Characteristics of Patients Who Completed the Program
| N | % | |
|---|---|---|
| Mean age, years (SD) | 55.9 | (10.0) |
| Gender | ||
| Female | 18 | 75.0 |
| Male | 6 | 25.0 |
| Cancer type (primary site) | ||
| Breast | 10 | 41.7 |
| Lung | 2 | 8.3 |
| Colon | 2 | 8.3 |
| Retroperitoneal | 2 | 8.3 |
| Bone and soft tissue | 1 | 4.2 |
| Hematological and lymph | 1 | 4.2 |
| Head and neck | 1 | 4.2 |
| Thymus | 1 | 4.2 |
| Ovary | 1 | 4.2 |
| Renal pelvis | 1 | 4.2 |
| Bladder | 1 | 4.2 |
| Unknown | 1 | 4.2 |
| Disease stage | ||
| 1 | 8 | 33.3 |
| 2 | 2 | 8.3 |
| 3 | 2 | 8.3 |
| 4 | 10 | 41.7 |
| Recurrence | 1 | 4.2 |
| Unknown | 1 | 4.2 |
| Performance status | ||
| 0 | 23 | 95.8 |
| 1 | 1 | 4.2 |
| Past treatmenta | 20 | 83.3 |
| Surgery | 17 | 70.8 |
| Chemotherapy | 14 | 58.3 |
| Radiation | 7 | 29.2 |
| Current treatment | 11 | 45.8 |
| Chemotherapy | 10 | 41.7 |
| Radiation | 1 | 4.2 |
| Scheduled treatmenta | 15 | 62.5 |
| Chemotherapy | 11 | 45.8 |
| Radiation | 3 | 12.5 |
| Surgery | 2 | 8.3 |
| Pharmacotherapya | 17 | 70.8 |
| Anxiolyticsa | 10 | 41.7 |
| Alprazolam | 8 | |
| Lorazepam | 2 | |
| Etizolam | 1 | |
| Antidepressantsa | 9 | 37.5 |
| Mirtazapine | 5 | |
| Trazodone | 3 | |
| Sertraline | 1 | |
| Escitalopram | 1 | |
| Duloxetine | 1 | |
| Sleeping pillsa | 8 | 33.3 |
| Zolpidem | 6 | |
| Triazolam | 1 | |
| Flunitrazepam | 1 | |
| Nitrazepam | 1 | |
| Antipsychotics | 1 | 4.2 |
| Aripiprazole | 1 | |
| Education status | ||
| College | 10 | 41.7 |
| High school | 8 | 33.3 |
| Junior college | 4 | 16.7 |
| Vocational school | 2 | 8.3 |
| Social status | ||
| Unemployed | 15 | 62.5 |
| Employed | 9 | 37.5 |
| Living | ||
| With someone else | 21 | 87.5 |
| Alone | 3 | 12.5 |
| Marital status | ||
| Married | 21 | 87.5 |
| Unmarried | 3 | 12.5 |
| Parent | ||
| Yes | 17 | 70.8 |
| No | 7 | 29.2 |
| Past psychiatric history | ||
| No | 15 | 62.5 |
| Yes | 9 | 37.5 |
a
Including duplicates.
SD, standard deviation.